Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 4, 2025 • 7:00 AM ET

Date/Time Source News Release
11/29/2024 04:30 PM EST GlobeNewswire Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
11/25/2024 08:00 AM EST GlobeNewswire Cue Biopharma to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference
11/14/2024 04:05 PM EST GlobeNewswire Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights
11/14/2024 08:00 AM EST GlobeNewswire Cue Biopharma Announces Strategic Organizational Transition
11/12/2024 08:00 AM EST GlobeNewswire Cue Biopharma to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference
11/08/2024 01:30 PM EST GlobeNewswire Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting
10/04/2024 09:00 AM EDT GlobeNewswire Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer's (SITC) 39th Annual Meeting
09/26/2024 11:26 PM EDT GlobeNewswire Cue Biopharma Announces Pricing of $12.0 Million Public Offering
09/26/2024 04:27 PM EDT GlobeNewswire Cue Biopharma Announces Proposed Public Offering
09/09/2024 08:00 AM EDT GlobeNewswire Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Business Officer
Page

Additional News

As of January 4, 2025 • 7:00 AM ET

Date/Time Source News Release
11/15/2024 11:15 AM EST KlickAnalytics CUE Price Target Alert: $4.00. Issued by Jefferies
11/15/2024 09:15 AM EST KlickAnalytics Buy Recommendation Issued On CUE By Jefferies
11/15/2024 05:06 AM EST SeekingAlpha Cue Biopharma GAAP EPS of -$0.17 beats by $0.02, revenue of $3.34M beats by $1.82M
11/14/2024 05:25 PM EST Zacks Cue Biopharma, Inc. (CUE) Reports Q3 Loss, Tops Revenue Estimates
11/14/2024 08:33 AM EST SeekingAlpha Cue names Daniel Baker interim CDO, CSO Anish Suri to transition to advisor role
11/14/2024 08:33 AM EST SeekingAlpha Cue names Daniel Baker interim CDO, CSO Amish Suri to transition to advisor role
11/14/2024 06:00 AM EST US Earnings Reports Expected US Company Earnings on Thursday, November 14th, 2024
11/14/2024 04:40 AM EST US Earnings Reports Expected earnings - Cue Biopharma Inc.
11/13/2024 05:25 PM EST Zacks Ontrak, Inc. (OTRK) Reports Q3 Loss, Lags Revenue Estimates
11/12/2024 08:15 AM EST Zacks Axsome Therapeutics (AXSM) Reports Q3 Loss, Tops Revenue Estimates
Page